1-10 of 10
Joanne D Hewitt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide Maintenance Does Not Negatively Impact Overall and Progression Free Survival Using Lenalidomide-Based Regimens for Multiple Myeloma in First Relapse

Free
Hannah Cherniawsky, BSc,MD, Zack M. Breckenridge, BSc, Irwindeep Sandhu, MD FRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew R Belch, MD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner, MD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): 5643.
https://doi.org/10.1182/blood-2018-99-117705
Published: 2018
Journal Articles

The Survival Impact of Lenalidomide Maintenance Chemotherapy in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplant and Bortezomib-Based Induction: An Analysis of Real World Data

Free
Hannah Cherniawsky, BSc, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Joanne D. Hewitt, NP, PhD, Ismail Ismail, Andrew Belch, Linda M. Pilarski, PhD, Tatiana Nikitina, PhD, Christopher P. Venner, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3132.
https://doi.org/10.1182/blood.V130.Suppl_1.3132.3132
Published: 2017
Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Free
Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1928.
https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928
Published: 2017
Journal Articles

The Evolving Impact on Survival Outcomes in Multiple Myeloma with Greater Access to Novel Treatment Regimens: Experience in a Real-World Cohort

Free
Zack M. Breckenridge, BSc, Victor Jimenez-Zepeda, MD, Nizar J. Bahlis, MD, Paola Neri, MD, Irwindeep Sandhu, MDFRCPC, Michael P. Chu, MD, Ismail Ismail, Jason Tay, MD FRCPC, Peter Duggan, MD FRCPC, Andrew Belch, Joanne D. Hewitt, NP, PhD, Linda M. Pilarski, PhD, Tatiana Nikitina, Christopher P. Venner
Journal: Blood
Blood (2017) 130 (Supplement 1): 1859.
https://doi.org/10.1182/blood.V130.Suppl_1.1859.1859
Published: 2017
Journal Articles

Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy

Free
Michael P. Chu, MD, Christopher P. Venner, MD, Irwindeep Sandhu, MD, Eva Baigorri, PhD, Jitra Kriangkum, PhD, Joanne D Hewitt, RN, BSN, NP, Andrew Belch, Linda M. Pilarski, PhD
Journal: Blood
Blood (2016) 128 (22): 2113.
https://doi.org/10.1182/blood.V128.22.2113.2113
Published: 2016
Journal Articles

In Multiple Myeloma Progression Free and Overall Survival in the Relapsed Setting Remains Poor with Early Exposure to Novel Agents: Experience from a Real-World Cohort

Free
Christopher P. Venner, MD, Nizar J Bahlis, MD, Paola Neri, MD PhD, Irwindeep Sandhu, MD, Peter Duggan, MD, Andrew Belch, MD, Joanne D Hewitt, RN, BSN, NP, Linda M. Pilarski, PhD, Tatiana Nikitina, Victor H Jimenez-Zepeda, MD
Journal: Blood
Blood (2015) 126 (23): 4261.
https://doi.org/10.1182/blood.V126.23.4261.4261
Published: 2015
Journal Articles

Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to Lenalidomide and Dexamethasone (LD) for the Treatment of Non-Transplant Eligible Multiple Myeloma

Free
Victor H Jimenez-Zepeda, MD, Christopher P. Venner, MD, Andrew Belch, Irwindeep Sandhu, MD, Tatiana Nikitina, Joanne D Hewitt, RN, BSN, NP, Peter Duggan, MD, Paola Neri, MD PhD, Fariborz Rashid-Kolvear, PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2015) 126 (23): 1845.
https://doi.org/10.1182/blood.V126.23.1845.1845
Published: 2015
Journal Articles

Pomalidomide-Containing Regimens (PCR) for the Treatment of Relapsed and Refractory Multiple Myeloma

Free
Victor H Jimenez-Zepeda, MD, Christopher P. Venner, MD, Andrew Belch, Irwindeep Sandhu, MD, Tatiana Nikitina, Joanne D Hewitt, RN, BSN, NP, Peter Duggan, MD, Paola Neri, MD PhD, Fariborz Rashid-Kolvear, PhD, Nizar J Bahlis, MD
Journal: Blood
Blood (2015) 126 (23): 5384.
https://doi.org/10.1182/blood.V126.23.5384.5384
Published: 2015
Journal Articles

A Population (Registry) Based Analysis of the Impact of Bcr-Abl Specific Tyrosine Kinase Inhibition on Survival after Diagnosis of Philadelphia Chromosome Positive Chronic Myelogenous Leukemia..

Free
A. Robert Turner, MD, Joanne D Hewitt, BSN, NP, Anmmd Kamruzzaman, M.Sc, Loree M. Larratt, MD, Deborah A. Rusnak, BSN, Nanette Cox-Kennett, MSN, NP, Andrew R. Belch, MD
Journal: Blood
Blood (2008) 112 (11): 3237.
https://doi.org/10.1182/blood.V112.11.3237.3237
Published: 2008
Journal Articles

HyperCKemia in CML Patients on Imatinib Mesylate.

Free
Joanne D. Hewitt, BScN, Deborah A. Rusnak, RN, Nanette Cox-Kennett, MN, Loree M. Larratt, MD, Robert Turner, MD
Journal: Blood
Blood (2007) 110 (11): 2965.
https://doi.org/10.1182/blood.V110.11.2965.2965
Published: 2007